from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3916c/-

LFCtreatmentdescriptionclass of inhibitor

-0.321

Amikacinug/mL Amikacintranslation

0.063

Cap5-10ug/mL Capreomycintranslation

-0.169

Rox10-50 ug/mL Roxithromycintranslation

-0.701

SM2-5 ug/mL Streptomycintranslation

0.057

Tet5-10 ug/mL Tetracyclinetranslation

0.203

Rif0.2-5ug/mL Rifampicintranscription

0.211

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.737

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.585

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.773

CPZ10-50 ug/mL Chlorpromazinerespiration

1.373

Clofazimine10-13 ug/mL Clofaziminerespiration

0.305

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.438

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.591

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.848

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.130

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.377

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.321

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.237

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.577

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.261

KCN5-20 ug/mL Potassium cyaniderespiration

-0.180

NaN30.2-2 mM Sodium aziderespiration

-0.410

Nigericin50 uM Nigericinrespiration

0.675

TRC10-150 ug/mL Triclosanrespiration

1.032

TRZ10-25 ug/mL Thioridazinerespiration

2.405

Valinomycin0.5-10 uM Valinomycinrespiration

-2.143

ZnSO42 mM ZnSO4respiration

0.074

menadione6-10 ug/mL Menadionerespiration

0.256

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.641

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.078

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.201

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.448

NRP_1Non-replicating persistence stage 1dosRassociated

-0.706

Amp0.2mg/mL AmpicillincellWall

-0.787

Cephalexin20-100 ug/mL CephalexincellWall

-0.341

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.522

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.341

EMB10-20 ug/mL EthambutolcellWall

-0.986

Eta12-40 ug/mL EthionamidecellWall

-1.274

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.394

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.646

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.977

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.569

BZA0.12 mg/mL BenzamidearomaticAmides

-0.456

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.658

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.644

H2O24 mM hydrogen peroxideDNAdamaging

-0.433

Levo10 ug/mL LevofloxacinDNAdamaging

-0.362

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.205

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.141

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.612

UVUV-irradiationDNAdamaging

0.847

ARP41-4 ug/mL Antitubercular compound ARP4?

0.146

Antimycin12.5-50 ug/mL Antimycin A?

-0.477

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.097

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.353

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.125

PA8240.2-2 ug/mL PA-824?

1.094

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.217

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.926

Verapamil50 uM Verapamil?

-0.439

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.784

methoxatin10-20 ug/mL Methoxatin?